Capital Impact Advisors, LLC Danaher Corp Transaction History

Capital Impact Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 21, 2022	SELL	$247.06 - $1507.4 $119,824 - $731,089	-485 Reduced 39.98%	728 $188,000
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $327,448 - $413,830	-1,381 Reduced 53.24%	1,213 $308,000
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $1.16 Million - $1.43 Million	-4,514 Reduced 63.51%	2,594 $761,000
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $882,232 - $1.08 Million	3,241 Added 83.81%	7,108 $2.16 Million
Q2 2021 Aug 17, 2021	BUY	$225.08 - $271.69 $870,384 - $1.05 Million	3,867 New	3,867 $1.04 Million
Q1 2021 May 18, 2021	SELL	$212.38 - $245.9 $2.12 Million - $2.46 Million	-10,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $2.13 Million - $2.58 Million	-12,000 Reduced 54.55%	10,000 $2.15 Million
Q2 2020 Aug 17, 2020	BUY	$128.7 - $176.83 $900,256 - $1.24 Million	6,995 Added 46.62%	22,000 $3.89 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $490,148 - $530,221	3,620 Added 31.8%	15,005 $2.12 Million
Q1 2018 Apr 11, 2018	BUY	$92.16 - $103.8 $1.05 Million - $1.18 Million	11,385 New	11,385 $1.12 Million

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.